IPO Ideas
Asston Pharmaceuticals Limited IPO logo

Asston Pharmaceuticals Limited IPO

BBSMEBSEListed
Listed at
119
3.25%

Asston Pharmaceuticals Limited IPO is a SME book building IPO. Price band is ₹123 per share. Minimum investment is ₹2.46 L. Lot size is 1000 shares. Open from 9 Jul 2025 to 11 Jul 2025. Allotment on 14 Jul 2025. Listing on 16 Jul 2025 at BSE. Managed by Sobhagya Capital Options Ltd. Registrar: Maashitla Securities Private Limited. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Asston Pharmaceuticals Limited IPO overview

Asston Pharmaceuticals Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹123
Lot size
1000 shares / lot
Min investment
₹2,46,000
Issue open – close
9 Jul 2025 → 11 Jul 2025

Asston Pharmaceuticals Limited IPO important dates

Issue Opens
9 Jul 2025
Issue Closes
11 Jul 2025
Allotment
14 Jul 2025
Listing
16 Jul 2025

Asston Pharmaceuticals Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)22,0002,46,000
S-HNI (Min)33,0003,69,000
S-HNI (UPI)44,0004,92,000
S-HNI (Max)88,0009,84,000
B-HNI (Min)99,00011,07,000

About Asston Pharmaceuticals Limited IPO

From the company / RHP narrative.

Incorporated in 2019, Asston Pharmaceuticals Limited is engaged in the business of pharmaceuticals, specializing in exporting healthcare products globally.

The company offers a diverse range of products, including tablets, capsules, sachets, and syrups. Its product portfolio encompasses various therapeutic categories, such as analgesics, antibiotics, antifungals, vitamins, and more.

The company manufactures pharmaceutical products for direct sales and also on a contract manufacturing or loan license basis, primarily working on a principle-to-principle approach with various marketers.

The company is FDA certified by both Central and State FDA, accredited by NQA (Nuclear Quality Assurance), and complies with Quality Management System (QMS) standards, ensuring high-quality manufacturing.

Products:


Albendazole USP 400 mg: Albendazole USP 400 mg refers to a higher dosage of Albendazole, a broad-spectrum anthelmintic (anti-worm) medication that is used to treat various parasitic worm infections.
Diclofenac 100 mg: Diclofenac 100 mg refers to a specific dosage of Diclofenac, a widely used nonsteroidal anti-inflammatory drug (NSAID).
Ibuprofen, paracetamol: Ibuprofen and Paracetamol (Acetaminophen) are two commonly used over-the-counter medications, often used to relieve pain and reduce fever.
Ferrovit Syrup: To treat vitamin and mineral deficiencies.


As of 3 July 2025, the company has 46 Permanent employees and 6 contractual employees in various departments.

Competitive Strengths:


Formulation Expertise
Experienced Promoters
Wide range of Products
Strategic Location
Skilled Workforce

Objective of the issue

How the issuer plans to use IPO proceeds.

Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit

Funding the incremental working capital requirements of the Company

Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company

General Corporate Purposes
Asston Pharmaceuticals Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.

Documents & links

Prospectus, draft filings, and company site open in a new tab.

Registrar

Details about the registrar of the issue.

Registrar Name
Maashitla Securities Private Limited
Phone
4512179596
Address
451, Krishna Apra Business Square Netaji Subhash Place Pitampura, Delhi, 110034

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
BB
Face Value
10
Lead Managers
Sobhagya Capital Options Ltd
Min Quantity
2,000
Company Promoters
Dr. Ashish Narayan Sakalkar,Saili Jayaram
Phone
+91 22 49731411
Address
Asston Pharmaceuticals Ltd. 4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane Navi Mumbai, Maharashtra, 400614

Related articles

Research posts and updates that reference this company or theme.

Follow IPO & unlisted research in the app, available on iOS and Android.